Correlation Between GlaxoSmithKline PLC and Hyloris Developmentsen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Hyloris Developmentsen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Hyloris Developmentsen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Hyloris Developmentsen Sa, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Hyloris Developmentsen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Hyloris Developmentsen. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Hyloris Developmentsen.

Diversification Opportunities for GlaxoSmithKline PLC and Hyloris Developmentsen

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between GlaxoSmithKline and Hyloris is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Hyloris Developmentsen Sa in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hyloris Developmentsen and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Hyloris Developmentsen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hyloris Developmentsen has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Hyloris Developmentsen go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Hyloris Developmentsen

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Hyloris Developmentsen. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 7.14 times less risky than Hyloris Developmentsen. The stock trades about -0.3 of its potential returns per unit of risk. The Hyloris Developmentsen Sa is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  590.00  in Hyloris Developmentsen Sa on August 30, 2024 and sell it today you would lose (28.00) from holding Hyloris Developmentsen Sa or give up 4.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Hyloris Developmentsen Sa

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Hyloris Developmentsen 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Hyloris Developmentsen Sa are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak essential indicators, Hyloris Developmentsen may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and Hyloris Developmentsen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Hyloris Developmentsen

The main advantage of trading using opposite GlaxoSmithKline PLC and Hyloris Developmentsen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Hyloris Developmentsen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hyloris Developmentsen will offset losses from the drop in Hyloris Developmentsen's long position.
The idea behind GlaxoSmithKline PLC ADR and Hyloris Developmentsen Sa pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
CEOs Directory
Screen CEOs from public companies around the world
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon